Skip to main content
Erschienen in: Acta Neuropathologica 4/2005

01.04.2005 | Regular Paper

Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas

verfasst von: Anna Sjödin, Dongsheng Guo, Morten Lund-Johansen, Bård Kronen Krossnes, Peer Lilleng, Roger Henriksson, Håkan Hedman

Erschienen in: Acta Neuropathologica | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Secretoglobins are small secreted proteins, the expression of which has mostly been associated with secretory mucosal epithelia. Several secretoglobins have been implicated in the development of various human cancers. Allelic deletions of chromosome 11q13 correlates with the invasiveness of pituitary tumors. Intriguingly, several secretoglobin genes are located on 11q13; however, for most of these genes the expression in the pituitary and pituitary tumors have not been investigated. Antibodies specific for the secretoglobin lipophilin B (SCGB1D2, BU101) were developed and used in an immunohistochemical analysis of a human normal tissue microarray. Prominent lipophilin B immunoreactivity was found in the secretory cells of the anterior pituitary. Eight of nine analyzed pituitary adenomas showed a reduction in lipophilin B immunoreactivity compared to normal pituitary. However, there was no apparent association between lipophilin B immunoreactivity and hormone production or tumor invasiveness. Expression of eight different secretoglobin mRNAs were analyzed in normal pituitary and the pituitary adenoma cell line HP75 by highly specific quantitative real-time reverse transcription-PCR assays. Lipophilins B and C (SCGB2A1, mammaglobin B) were the most prominently expressed secretoglobin mRNAs in the pituitary. No secretoglobin mRNA was detected in the HP75 cells. The present report demonstrates, for the first time, lipophilin B expression in the pituitary and its apparent down-regulation in pituitary adenomas.
Literatur
1.
Zurück zum Zitat Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, Ledermann J, Boshoff C (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 90:686–692CrossRef Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, Ledermann J, Boshoff C (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 90:686–692CrossRef
2.
Zurück zum Zitat Austin CJ, Emberson L, Nicholls P (2004) Purification and characterization of pheromaxein, the porcine steroid-binding protein. A member of the secretoglobin superfamily. Eur J Biochem 271:2593–2606CrossRef Austin CJ, Emberson L, Nicholls P (2004) Purification and characterization of pheromaxein, the porcine steroid-binding protein. A member of the secretoglobin superfamily. Eur J Biochem 271:2593–2606CrossRef
3.
Zurück zum Zitat Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818–824CrossRef Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818–824CrossRef
4.
Zurück zum Zitat Becker RM, Darrow C, Zimonjic DB, Popescu NC, Watson MA, Fleming TP (1998) Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics 54:70–78CrossRef Becker RM, Darrow C, Zimonjic DB, Popescu NC, Watson MA, Fleming TP (1998) Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics 54:70–78CrossRef
5.
Zurück zum Zitat Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A (2000) Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci 923:68–77 Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A (2000) Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci 923:68–77
6.
Zurück zum Zitat Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, Fleming TP, Reed SG, Houghton RL, Diamond DL, Vedvick TS (2002) Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 41:6714–6722CrossRef Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, Fleming TP, Reed SG, Houghton RL, Diamond DL, Vedvick TS (2002) Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 41:6714–6722CrossRef
7.
Zurück zum Zitat Carter D, Dillon DC, Reynolds LD, Retter MW, Fanger G, Molesh DA, Sleath PR, McNeill PD, Vedvick TS, Reed SG, Persing DH, Houghton RL (2003) Serum antibodies to lipophilin B detected in late stage breast cancer patients. Clin Cancer Res 9:749–754 Carter D, Dillon DC, Reynolds LD, Retter MW, Fanger G, Molesh DA, Sleath PR, McNeill PD, Vedvick TS, Reed SG, Persing DH, Houghton RL (2003) Serum antibodies to lipophilin B detected in late stage breast cancer patients. Clin Cancer Res 9:749–754
8.
Zurück zum Zitat Colpitts TL, Billing-Medel P, Friedman P, Granados EN, Hayden M, Hodges S, Menhart N, Roberts L, Russell J, Stroupe SD (2001) Mammaglobin is found in breast tissue as a complex with bu101. Biochemistry 40:11048–11059CrossRef Colpitts TL, Billing-Medel P, Friedman P, Granados EN, Hayden M, Hodges S, Menhart N, Roberts L, Russell J, Stroupe SD (2001) Mammaglobin is found in breast tissue as a complex with bu101. Biochemistry 40:11048–11059CrossRef
9.
Zurück zum Zitat Klug J, Beier HM, Bernard A, Chilton BS, Fleming TP, Lehrer RI, Miele L, Pattabiraman N, Singh G (2000) Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci 923:348–354 Klug J, Beier HM, Bernard A, Chilton BS, Fleming TP, Lehrer RI, Miele L, Pattabiraman N, Singh G (2000) Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci 923:348–354
10.
Zurück zum Zitat Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617; discussion 617–618 Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617; discussion 617–618
11.
Zurück zum Zitat Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K (2001) HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci USA 98:9796–9801CrossRef Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K (2001) HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci USA 98:9796–9801CrossRef
12.
Zurück zum Zitat Lehrer RI, Xu G, Abduragimov A, Dinh NN, Qu XD, Martin D, Glasgow BJ (1998) Lipophilin, a novel heterodimeric protein of human tears. FEBS Lett 432:163–167CrossRef Lehrer RI, Xu G, Abduragimov A, Dinh NN, Qu XD, Martin D, Glasgow BJ (1998) Lipophilin, a novel heterodimeric protein of human tears. FEBS Lett 432:163–167CrossRef
13.
Zurück zum Zitat Marchetti A, Barassi F, Martella C, Chella A, Salvatore S, Castrataro A, Mucilli F, Sacco R, Buttitta F (2004) Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res 10:1338–1343 Marchetti A, Barassi F, Martella C, Chella A, Salvatore S, Castrataro A, Mucilli F, Sacco R, Buttitta F (2004) Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res 10:1338–1343
14.
Zurück zum Zitat Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S, Zheng F, Pattabiraman N, Zhang Z (1999) Uteroglobin: a novel cytokine? Cell Mol Life Sci 55:771–787CrossRef Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S, Zheng F, Pattabiraman N, Zhang Z (1999) Uteroglobin: a novel cytokine? Cell Mol Life Sci 55:771–787CrossRef
15.
Zurück zum Zitat Ni J, Kalff-Suske M, Gentz R, Schageman J, Beato M, Klug J (2000) All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster. Ann N Y Acad Sci 923:25–42 Ni J, Kalff-Suske M, Gentz R, Schageman J, Beato M, Klug J (2000) All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster. Ann N Y Acad Sci 923:25–42
16.
Zurück zum Zitat Nieto A, Ponstingl H, Beato M (1977) Purification and quaternary structure of the hormonally induced protein uteroglobin. Arch Biochem Biophys 180:82–92 Nieto A, Ponstingl H, Beato M (1977) Purification and quaternary structure of the hormonally induced protein uteroglobin. Arch Biochem Biophys 180:82–92
17.
Zurück zum Zitat Niimi T, Keck-Waggoner CL, Popescu NC, Zhou Y, Levitt RC, Kimura S (2001) UGRP1, a uteroglobin/Clara cell secretory protein-related protein, is a novel lung-enriched downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor. Mol Endocrinol 15:2021–2036CrossRef Niimi T, Keck-Waggoner CL, Popescu NC, Zhou Y, Levitt RC, Kimura S (2001) UGRP1, a uteroglobin/Clara cell secretory protein-related protein, is a novel lung-enriched downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor. Mol Endocrinol 15:2021–2036CrossRef
18.
Zurück zum Zitat Peri A, Cordella-Miele E, Miele L, Mukherjee AB (1993) Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein. J Clin Invest 92:2099–2109 Peri A, Cordella-Miele E, Miele L, Mukherjee AB (1993) Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein. J Clin Invest 92:2099–2109
19.
Zurück zum Zitat Sjodin A, Guo D, Hofer PA, Henriksson R, Hedman H (2003) Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol 121:428–429CrossRef Sjodin A, Guo D, Hofer PA, Henriksson R, Hedman H (2003) Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol 121:428–429CrossRef
20.
Zurück zum Zitat Sjodin A, Guo D, Sorhaug S, Bjermer L, Henriksson R, Hedman H (2003) Dysregulated secretoglobin expression in human lung cancers. Lung Cancer 41:49–56CrossRef Sjodin A, Guo D, Sorhaug S, Bjermer L, Henriksson R, Hedman H (2003) Dysregulated secretoglobin expression in human lung cancers. Lung Cancer 41:49–56CrossRef
21.
Zurück zum Zitat Stripp BR, Lund J, Mango GW, Doyen KC, Johnston C, Hultenby K, Nord M, Whitsett JA (1996) Clara cell secretory protein: a determinant of PCB bioaccumulation in mammals. Am J Physiol 271:L656–664 Stripp BR, Lund J, Mango GW, Doyen KC, Johnston C, Hultenby K, Nord M, Whitsett JA (1996) Clara cell secretory protein: a determinant of PCB bioaccumulation in mammals. Am J Physiol 271:L656–664
22.
Zurück zum Zitat Watson MA, Fleming TP (1994) Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54:4598–4602 Watson MA, Fleming TP (1994) Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54:4598–4602
23.
Zurück zum Zitat Watson MA, Fleming TP (1996) Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56:860–865 Watson MA, Fleming TP (1996) Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56:860–865
24.
Zurück zum Zitat Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP (1999) Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59:3028–3031 Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP (1999) Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59:3028–3031
25.
Zurück zum Zitat Weeraratna AT, Cajigas JA, Schwartz A, Enquist EG, Manyak MJ, Patierno SR (1997) Loss of uteroglobin expression in prostate cancer: relationship to advancing grade. Clin Cancer Res 3:2295–2300 Weeraratna AT, Cajigas JA, Schwartz A, Enquist EG, Manyak MJ, Patierno SR (1997) Loss of uteroglobin expression in prostate cancer: relationship to advancing grade. Clin Cancer Res 3:2295–2300
Metadaten
Titel
Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas
verfasst von
Anna Sjödin
Dongsheng Guo
Morten Lund-Johansen
Bård Kronen Krossnes
Peer Lilleng
Roger Henriksson
Håkan Hedman
Publikationsdatum
01.04.2005
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 4/2005
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-004-0972-6

Weitere Artikel der Ausgabe 4/2005

Acta Neuropathologica 4/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.